|Approval Date||25 Jan 2022|
|Signature Date||23 Mar 2022|
|Planned Completion Date||31 Mar 2024|
|Sovereign / Non-Sovereign||Sovereign|
|Sector||Industry, Minning & Quarrying|
|DAC Sector Code||32110|
The proposed intervention is an ADF Grant of UA 2.5 million to finance the Development of the Pharmaceutical Industry in the ECOWAS Region. It is designed to enhance the institutional Capacities of National Medicines Regulatory Authorities (NMRAs), the Regional Quality Control Laboratories, and Regional Training Institutions to support the development of the pharmaceutical industry in the ECOWAS region. This will support the development of a robust pharmaceutical industry in the ECOWAS region that is capable of locally manufacturing medicines and vaccines that are safe, affordable, and accessible to the people of the region. The project is comprised of three components, which are outlined as follows: (i) Provide Institutional Support for the ECOWAS Pharmaceutical Sector Development (ii) Provide Capacity Building and Advisory Services for the ECOWAS Pharmaceutical Sector and (iii) Provide Management and Coordination. This project aims to support the ADF eligible countries in the ECOWAS region to develop a robust and competitive pharmaceutical sector that ensures increased local manufacturing of essential drugs, medicines and vaccines that are of high quality, safe, effective, and meets the challenges of diseases and pandemics. In addition, enhancing standards of production is central to increased security of supply of essential medicines for malaria, TB, HIV/AIDS, Diabetes, Hypertension, maternal and child health illnesses and other tropical and infectious diseases. The project is designed to be implemented over a period of two (2) years, starting from April 2022 to April 2024.
The overall objective of this project is to develop a robust pharmaceutical sector that will ensure increased local manufacturing of essential drugs and medicines that are of high quality, safe, and accessible to the people of the region. The specific objectives include: (i) Provide support for the implementation of the regulation on the zero tariff on pharmaceutical raw materials, packaging and finished products within the ECOWAS CET; (ii) Develop an effective regional pharmaceutical regulatory ecosystem through the provision of technical and capacity building programs that are gender responsive to regional medicines regulatory authorities (iii) Increase the industry’s competitiveness through improvement in quality standards; continuous product improvements; enhanced environmental/ecological responsibility; increase in production & distribution efficiencies; creates employment; enhance sales and marketing efforts; (iv) Ensure that the region complies with the global good manufacturing practice (GMP) in local production of pharmaceutical products and supplies; and (v) Capacitate the regional training institutions and laboratories to ensure that the requisite skills are available to support the growth of the industry in the region that is gender diverse and eco-friendly.
The target area of this project is the ECOWAS region, comprising 15 member countries with a large population of nearly 400 million people. The scope of the project is regional, aimed at strengthening the ECOWAS regional pharmaceutical support institutions, including the Medicines Regulatory Authorities (MRAs), quality control laboratories, and regional pharmaceutical training institutions. The pharmaceutical industries will benefit indirectly through improved regulatory frameworks, efficient service delivery from public pharmaceutical institutions, and improved enabling environment for increased investment in the sector. The ultimate goal is to develop the pharmaceutical sector capable of locally manufacturing essential medicines that are safe, efficacious, and affordable to the people of the region.
African Development Fund
|Last Update||16 May 2022|